LAMISIL 1 %, solution as a cutaneous spray bottle, 15 ml
Active ingredients: Terbinafine hydrochloride
Commercialized according to BDPMDispensing in France: Prescription only
Solution for sprayingbottle, 15 mlcutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LAMISIL 1 %, solution pour pulvérisation cutanée
- Pharmaceutical form
- solution pour pulvérisation
- Route of administration
- cutanée
- Presentation description
- 1 flacon(s) polyéthylène haute densité (PEHD) avec dispositif(s) pulvérisateur(s) de 15 ml
- Marketing authorisation holder
- KARO HEALTHCARE (SUEDE)
- Reimbursement according to BDPM
- 30%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 8 Apr 2002
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66102835CIP73558553CIP133400935585530Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE TERBINAFINEsolution | 1 g · 100 g | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.